Technical Data
A1059-69B
AHA1 (Activator of Hsp90 ATPase 1)
Description:
AHA1 is a cochaperone that stimulates HSP90 ATPase activity. It may affect a step in the endoplasmic reticulum to Golgi trafficking. AHA1 interacts with HSPCA/HSP90 and the cytoplasmic tail of the vesicular stomatitis virus glycoprotein. The protein is expressed in numerous tissues, including brain, heart, skeletal muscle, kidney, liver, and placental tissues.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 0.05-0.2ug/ml
Western Blot: 0.5-1ug/ml
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20°C. Reconstitute with sterile 40-50% glycerol, aliquot and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
40ug-20°CBlue IceHumanRabbit
Concentration:
~0.5mg/ml
Immunogen:
Synthetic peptide (KLH). within carboxyl terminal of human AHA1 protein (Swiss Prot: O95433).
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a lyophilized powder in PBS, pH 7.4, 0.02% sodium azide.
Specificity:
Recognizes human AHA1 protein.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.